Elpic Pharma Private Limited

Elpic Pharma Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U24233MH2013PTC245568 Incorporated 12 July 2013 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹45.53 Lakh
▼ 15% YoY
Net profit · FY 2025
₹1.12 Lakh
Net margin 2.5%
EBITDA · FY 2025
₹1.53 Lakh
EBITDA margin 3.4%
Authorised capital
₹2 Lakh
Registered with MCA
Paid-up capital
₹1.5 Lakh
Issued & subscribed
Company age
13 yrs
Est. 2013
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Elpic Pharma Private Limited

Data last updated:

Elpic Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 12 July 2013 and has been in existence for over 13 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24233MH2013PTC245568. Its GSTIN is 09AADCE6899F1Z4 (Uttar Pradesh).

The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1.5 Lakh. It is led by directors Varsha Singhal and Sushila Bhati.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Mumbai, Maharashtra.

As per the financials filed for FY 2025, the company reported a revenue of ₹45.53 Lakh, a decline of 15% compared to the previous year. For the same year it recorded a net profit of ₹1.12 Lakh (net margin 2.5%) and EBITDA of ₹1.53 Lakh (EBITDA margin 3.4%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 3% over five years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Elpic Pharma Private Limited
CIN U24233MH2013PTC245568
Registration Number 245568
Incorporation Date 12 July 2013
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    Times Square 7th & 8th Floor Cts No. 349 & 349 – 1 W. E. Highway Nr. Sai Service Andheri, East, Mumbai, Maharashtra, India – 400069
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Elpic Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Elpic Pharma Private Limited report

Financials, compliance, directors, charges, ownership and filings for Elpic Pharma Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Elpic Pharma Private Limited

The main business activity of Elpic Pharma is administrative and support service activities. In detail, this covers office administrative, office support and other business support activities.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
NAdministrative and support service activities82Office administrative, office support and other business support activitiesLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Elpic Pharma Private Limited FY 2024 filings available

Elpic Pharma Private Limited reported revenue of ₹45.53 Lakh (down 15% YoY) for FY 2025.

Revenue · FY 2025
₹45.53 Lakh ▼ 15%
Net profit · FY 2025
₹1.12 Lakh margin 2.5%
EBITDA · FY 2025
₹1.53 Lakh margin 3.4%

Compounded Annual Growth Rate (CAGR) of Elpic Pharma Private Limited

Revenue CAGR growth
1 year
▼ 15%
3 years · compounded
▲ 1%
5 years · compounded
▲ 3%
EBITDA CAGR growth
1 year
▼ 11%
3 years · compounded
▲ 28%
5 years · compounded
▲ 24%

Revenue fell 15% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 3%. EBITDA fell 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Elpic Pharma Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹1.53 Lakh••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹1.12 Lakh••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Elpic Pharma Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin3.4%••••••••••••••••
Net Profit Margin2.5%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Elpic Pharma are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Elpic Pharma Private Limited

Elpic Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
VMV Pharmaceutical India Private Limited₹45.9 Lakh (FY 2019)••••••••-37.0%••••Delhi, India
Progress Pharma Private Limited₹45.85 Lakh (FY 2024)••••••••-35.0%••••New Delhi, Delhi, India
Consern Cosmoceuticals Private Limited₹45.69 Lakh (FY 2024)••••••••50.0%••••Mumbai, Maharashtra, India
Moulik Pharmaceutical Private Limited₹45.58 Lakh (FY 2025)••••••••-21.0%••••Goalpara, Assam, India
Nanotek Remedies Private Limited₹45.57 Lakh (FY 2025)••••••••-23.0%••••Mumbai, Maharashtra, India
Elpic Pharma Private Limited this company₹45.53 Lakh (FY 2025)••••••••-15.0%••••Mumbai, Maharashtra, India
Glenwood Biotech Private Limited₹45.51 Lakh (FY 2018)••••••••50.0%••••Visakhapatnam, Andhra Pradesh, India
Elpida Healthcare Private Limited₹45.47 Lakh (FY 2025)••••••••83.0%••••Bangalore, Karnataka, India
Pahel Development Services Private Limited₹45.45 Lakh (FY 2017)••••••••-37.0%••••Faizabad, Uttar Pradesh, India
Peak Agencies Pvt Ltd₹45.39 Lakh (FY 2021)••••••••252.0%••••Mumbai, Maharashtra, India
Ewns Pharma Private Limited₹45.27 Lakh (FY 2025)••••••••-6.0%••••Meerut, Uttar Pradesh, India

Peers are the five companies nearest above and the five nearest below Elpic Pharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Elpic Pharma Private Limited

Elpic Pharma Private Limited is audited by A T K & ASSOCIATES for the financial year 2022.

NameStatusAppointment DateCessation Date
A T K & ASSOCIATESLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Elpic Pharma Private Limited

Elpic Pharma has 2 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Varsha SinghalDirector23 Jul 20206 Years 2 MonthsCurrent
Sushila BhatiDirector23 Jul 20206 Years 2 MonthsCurrent

Ownership and Shareholding of Elpic Pharma Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Elpic Pharma Private Limited

Elpic Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Elpic Pharma Private Limited

Employment history and EPFO contributions of people linked to Elpic Pharma.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Elpic Pharma Private Limited

Elpic Pharma Private Limited has 9 board changes on record since 2015: 2 appointments and 7 cessations. The latest: Sushila Bhati ceased to be Additional Director on 31 Dec 2020.

AGM
Elpic Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Elpic Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Ceased
Sushila Bhati ceased to be Additional Director.
Ceased
Varsha Singhal ceased to be Additional Director.
Ceased
Amar Nath ceased to be Director.
Ceased
Sonia Arora ceased to be Director.
Appointed
Sushila Bhati was appointed as Director.
Appointed
Varsha Singhal was appointed as Director.
Ceased
Sachin Arora ceased to be Director.
Ceased
Pravesh Kumar Tyagi ceased to be Director.
Ceased
Tapesh Bhati ceased to be Director.
Incorporation
12 Jul 2013
Elpic Pharma Private Limited was registered on 12 Jul 2013 with Roc Mumbai & aged 13 years 2 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Elpic Pharma Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Elpic Pharma Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Elpic Pharma Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Elpic Pharma Private Limited

Elpic Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
09AADCE6899F1Z4Uttar PradeshActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Elpic Pharma Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Elpic Pharma Private Limited

Elpic Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 12 July 2013 (13+ years old) and is registered under CIN U24233MH2013PTC245568.

Elpic Pharma reported revenue of ₹45.53 Lakh for FY 2025 (down 15% YoY).

Elpic Pharma has 2 current directors:

Elpic Pharma reported a net profit of ₹1.12 Lakh (net margin 2.5%) and EBITDA of ₹1.53 Lakh (EBITDA margin 3.4%) for FY 2025, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Elpic Pharma is 1% over three years and 3% over five years. In the latest year (FY 2025) revenue fell 15%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Elpic Pharma is 09AADCE6899F1Z4, registered in Uttar Pradesh.

The CIN (Corporate Identification Number) of Elpic Pharma is U24233MH2013PTC245568. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Elpic Pharma was incorporated on 12 July 2013, making it 13+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of Elpic Pharma by revenue are VMV Pharmaceutical India Private Limited, Progress Pharma Private Limited, Consern Cosmoceuticals Private Limited, Moulik Pharmaceutical Private Limited, Nanotek Remedies Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).

Sushila Bhati ceased to be Additional Director on 31 Dec 2020. Varsha Singhal ceased to be Additional Director on 31 Dec 2020. Amar Nath ceased to be Director on 24 Jul 2020. Elpic Pharma has 9 board changes on record in total.

The registered office of Elpic Pharma is at Times Square 7th & 8th Floor Cts No. 349 & 349 – 1 W. E. Highway Nr. Sai Service Andheri, East, Mumbai, Maharashtra, India – 400069.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available